Who owns CCCC?
Institutional ownership of C4 Therapeutics Inc. from Form 13F, Q2 2026
148 institutional managers reported holding C4 Therapeutics Inc. (CCCC) in Form 13F filings for Q2 2026, with 117,624,878 shares worth $548M. The largest reported holder was Morgan Stanley. Managers that filed both quarters added a net 32,680,405 shares (+38.5%). 52 opened new positions and 27 sold out.
- Funds holding
- 148
- Value held
- $548M
- New / sold out
- 52 / 27
- Net shares, same filers
- +38.5%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of CCCC
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Morgan Stanley | $41.4M | 7.5% | 8,867,338 | Trimmed |
| Ra Capital Management, L.p. | $37.4M | 6.8% | 8,000,000 | Unchanged |
| BlackRock, Inc. | $36.9M | 6.7% | 7,896,718 | Added |
| Lynx1 Capital Management LP | $34.2M | 6.2% | 7,326,691 | Added |
| Squadron Capital Management LLC | $33.6M | 6.1% | 7,200,000 | Added |
| Bain Capital Life Sciences Investors, LLC | $33.5M | 6.1% | 7,171,910 | Unchanged |
| JPMorgan Chase & Co | $20.7M | 4.0% | 4,747,424 | Added |
| Vanguard Capital Management LLC | $20.6M | 3.8% | 4,417,731 | Added |
| Citadel Advisors LLC | $19.6M | 3.6% | 4,187,580 | Added |
| Goldman Sachs Group Inc | $16.5M | 3.0% | 3,530,991 | Added |
| Wasatch Advisors LP | $16.5M | 3.0% | 3,522,644 | Added |
| Two Sigma Investments, LP | $16.2M | 2.9% | 3,469,707 | Added |
| Soleus Capital Management, L.P. | $15.8M | 2.9% | 3,377,981 | Trimmed |
| Silverarc Capital Management, LLC | $14.2M | 2.6% | 3,032,060 | Added |
| Bank of America Corp | $12.4M | 2.3% | 2,656,359 | Added |
| Geode Capital Management, LLC | $11.8M | 2.1% | 2,522,163 | Added |
| Ikarian Capital, LLC | $11.4M | 2.1% | 2,433,000 | New |
| State Street Corp | $9.9M | 1.8% | 2,115,621 | Added |
| Acadian Asset Management LLC | $8.4M | 1.5% | 1,806,199 | Trimmed |
| Candriam S.C.A. | $8.4M | 1.5% | 1,796,937 | New |
| D. E. Shaw & Co., Inc. | $8.1M | 1.5% | 1,740,989 | Added |
| Susquehanna International Group, LLP | $8.1M | 1.5% | 1,732,210 | Added |
| Patient Square Capital LP | $7.5M | 1.4% | 1,608,815 | New |
| HighVista Strategies LLC | $6.3M | 1.1% | 1,348,136 | New |
| Renaissance Technologies LLC | $5.6M | 1.0% | 1,189,828 | Trimmed |
Share of 13F holdings is each fund's shares as a share of the 117,624,878 CCCC shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- BlackRock, Inc. Added+$27.3M
- Squadron Capital Management LLC Added+$23.1M
- Ikarian Capital, LLC New+$11.4M
- Candriam S.C.A. New+$8.4M
- State Street Corp Added+$8.1M
- Citadel Advisors LLC Added+$7.8M
- Patient Square Capital LP New+$7.5M
- Geode Capital Management, LLC Added+$7.3M
- JPMorgan Chase & Co Added+$6.6M
- HighVista Strategies LLC New+$6.3M
Biggest sellers in Q2 2026
- Renaissance Technologies LLC Trimmed-$5.9M
- Millennium Management LLC Trimmed-$5.5M
- Jane Street Group, LLC Trimmed-$4.4M
- Orbimed Advisors LLC Sold out-$2.3M
- Soleus Capital Management, L.P. Trimmed-$2.0M
- Wells Fargo & Company Trimmed-$1.9M
- Stempoint Capital LP Trimmed-$1.8M
- Qube Research & Technologies Ltd Trimmed-$1.8M
- Barclays PLC Trimmed-$1.1M
- Jacobs Levy Equity Management, Inc Trimmed-$1.1M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $193M and sold $36.0M; 53 added and 28 trimmed.
Schedule 13D and 13G filings on CCCC
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-07-27BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2025-10-24RA CAPITAL MANAGEMENT, L.P. SCHEDULE 13G filed by C4 Therapeutics Inc.Schedule 13G
- 2025-10-20Point72 Asset Management, L.P. SCHEDULE 13G filed by C4 Therapeutics Inc.Schedule 13G
- 2025-02-03MORGAN STANLEY SCHEDULE 13G filed by C4 Therapeutics Inc.Schedule 13G
Questions about CCCC ownership
- Who owns CCCC stock?
- 148 institutional investment managers reported CCCC positions in their Form 13F filings for Q2 2026, holding 117,624,878 shares worth $548M in total. Morgan Stanley reported the largest position.
- Are funds buying or selling CCCC?
- In Q2 2026, 52 managers opened new CCCC positions, 53 added, 28 trimmed and 27 sold out. Managers that filed in both quarters added a net 32,680,405 shares.
- How current is this CCCC institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to CCCC by CUSIP. Options are left out. CCCC news and filings · CCCC insider trades · Top funds